Fundraising Fox
/Companies
Sign in

Bullseye Biosciences

4 known investors

Find your way into Bullseye Biosciences

Sign up to see every warm intro you have to Bullseye Biosciences

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Bullseye Biosciences team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Bullseye Biosciences uses in-cell directed evolution to discover functional therapeutic molecules against challenging intracellular targets such as protein–protein interactions and transcriptional regulation. Its platform selects molecules like macrocyclic and stapled peptides based on their biological effect inside living cells, with applications in oncology, immunology, and other serious diseases.

BiotechDeep Tech

Founders & leadership

CGCorey Gray
Corey GrayCo-founder and CEO
MMMichael McKeown
Michael McKeownCo-founder and Head of ResearchHe serves as an advisor and scientific consultant for Longtail Healthcare Ventures.

Investors · 4

KdT Ventureslisted by KdT VenturesAustin · $500K – $3M

How we know: KdT Ventures's portfolio page · Not right? Tell us

Undeterred Capitallisted by Undeterred CapitalLos Angeles · $500K – $1M

How we know: Undeterred Capital's portfolio page · Not right? Tell us

ZAKA VClisted by ZAKA VCSan Francisco

How we know: ZAKA VC's portfolio page · Not right? Tell us

Related companies · 4

bioBIO is the world's largest advocacy association representing biotechnology companies and research institutions across the United States and 30+ other nations. The organization facilitates industry networking through events, conferences, and partnering software while providing cost-savings programs and advocacy services for member companies.
Ideaya BiosciencesIDEAYA is a precision medicine oncology company developing first-in-class targeted therapies and rational drug combinations for molecularly defined, hard-to-treat cancers. Its lead candidate, darovasertib, is in late-stage trials for uveal melanoma, with a pipeline spanning PKC inhibition, ADC+DDR combinations, the MTAP pathway, and KAT6/7 inhibition.
AmbrosiabiosciencesAmbrosia Biosciences is a drug discovery company developing orally delivered, small molecule therapies for obesity and other metabolic disorders. It operates U.S.-based biology and chemistry laboratories along with an NMR facility and structural biology and computational chemistry capabilities to advance programs from hit to IND.
Blaze BioscienceBlaze Bioscience is a biotechnology company developing fluorescence imaging agents that let surgeons see cancer tissue in real time during surgery. Its Tumor Paint technology and lead candidate tozuleristide (BLZ-100) aim to improve precision in cancer surgery, with current work in breast-conserving surgery.

Companies working in the same space as Bullseye Biosciences.

Frequently asked questions

What does Bullseye Biosciences do?
Bullseye Biosciences uses in-cell directed evolution to discover functional therapeutic molecules against challenging intracellular targets such as protein–protein interactions and transcriptional regulation. Its platform selects molecules like macrocyclic and stapled peptides based on their biological effect inside living cells, with applications in oncology, immunology, and other serious diseases.
Who founded Bullseye Biosciences?
Bullseye Biosciences was founded by Corey Gray, Michael McKeown.
Who are Bullseye Biosciences's investors?
Bullseye Biosciences's investors include Illumina Ventures, KdT Ventures, Undeterred Capital, ZAKA VC.